Get the latest tech news
Dexcom Stelo is the 1st glucose monitor for those with prediabetes condition
The Dexcom Stelo is the first blood sugar monitor for people who don't have diabetes yet, with no prescription required.
Dexcom Stelo wearable has a 15-day battery life, compared to 10 days five years ago.In a patient with Type 1 diabetes, the pancreas can’t produce the hormone insulin, which helps the body absorb sugar and remove it from your bloodstream. With the launch of Stelo, we’re defining a brand-new category and once again setting the gold standard for people to easily take control of their health,” said Jake Leach, executive vice president and chief operating officer at Dexcom, in a statement. Both systems require a prescription and are reimbursed by 97% of commercial insurers in the U.S., Medicare nationally and Medicaid in most states.5 Stelo is designed for adults with Type 2 diabetes not using insulin or prediabetes who seek behavior change and optimized health and who do not haveinsurance coverage for glucose biosensors.
Or read this on Venture Beat